Уровень цитокинов в плазме крови некурящих и курящих пациентов с хронической обструктивной болезнью легких
Aliaksei G. Kadushkin, А. Д. Таганович, Л. В. Картун et al. · Пульмонология · 2014
Summary. The study has been carried out to investigate changes in interkeukins 1β (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), and interferon γ (IFN-γ) in never smoking patients with chronic obstuctive pulmonary disease (COPD) and smokers with COPD. We examined 21 non-smokers with COPD, 20 smokers with COPD, 20 healthy non-smokers and 21 healthy smokers. Serum levels of six inflammatory mediators were determined by the immunoassay method. IL-8 serum concentration was significantly elevated in smokers with COPD compared with healthy smokers and in non-smoking COPD patients compared with healthy non-smokers. Increased levels of TNF-α and IFN-γ were observed only in non-smoking COPD patients compared with non-smoking healthy controls. COPD patients with severe and very severe decrease in quality of life (according to COPD Assessment Test) had significantly higher TNF-α and IFN-γ levels than patients with mild and moderate decrease in quality of life. IL-1β, IL-6 and IL-10 levels did not differ significantly between the groups. Our findings suggest a possible role of IL-8, TNF-α and IFN-γ in the pathogenesis of COPD.
Cited by 1 works. doi:10.18093/0869-0189-2013-0-6-718-723
Authors
References
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
- Standardisation of the measurement of lung volumes
- Development and first validation of the COPD Assessment Test
- Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
- Neutrophil receptors for interleukin-8 and related CXC chemokines.
- Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
- Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function
- Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients
- Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
- Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers